A. Ritchie

Interferon‐alpha and survival in renal cell cancer

Sophie D. Fosså, Monica Jones, Peter Johnson et al. · British Journal of Urology · 1995 · 42 citations

Medicine, Oncology, Radiation Oncology +13

Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma

Sarah Pratap, ISD Roberts, Jane Collier et al. · BMC Cancer · 2012 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

On the development of the medical research council trial of α‐interferon in metastatic renal carcinoma

Peter Fayers, Pat Cook, David Machin et al. · Statistics in Medicine · 1994 · 20 citations

Medicine, Oncology, Pharmacotherapy +16

Primary efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: An international, randomised double-blind phase III trial led by the MRC CTU at UCL

Tim Eisen, Eleni Frangou, Ben Smith et al. · Annals of Oncology · 2019 · 16 citations

Medicine, Oncology, Pharmacotherapy +14

NATALI--a model for National Computer Databases in the investigation of new therapeutic techniques.

B.D. Braithwaite, A. Ritchie, J J Earnshaw · PubMed · 1995 · 10 citations

Health Professions, Biomedical Informatics, Health Informatics +17